HK Stock MarketDetailed Quotes

02291 SCIENTECH

Watchlist
  • 26.200
  • -1.300-4.73%
Market Closed Mar 28 16:08 CST
9.08BMarket Cap54.36P/E (TTM)

About SCIENTECH Company

Lepuxintai Medical Technology (Shanghai) Co., Ltd. is committed to providing safe, effective and innovative medical solutions. It is a pioneer in the structural heart disease interventional medical device industry in China and a large-scale domestic supplier of congenital heart disease blocking devices. Focus on R&D, production and marketing of medical interventional devices for structural heart disease. Currently, there are 50 products on the market and under development. The product line covers the congenital blocker series for interventional treatment of congenital heart disease, the left ventricular occlusion series for the prevention of cardiogenic stroke and the unclosed occlusion of the ovary, etc., and the biological interventional valve series for treatment of valve stenosis and incomplete closure, which can provide a comprehensive solution for structural heart disease interventional treatment. Our products have been sold overseas to 44 countries and regions in Asia, Europe, America and Africa. The company has strong R&D capabilities, has many innovative products with independent intellectual property rights, and is first involved in the research and development of biodegradable technology. In 2009, the “Development and Clinical Application of Interventional Treatment Series Blockers and Related Devices for Interventional Treatment of Defective Congenital Heart Disease” project won the second prize of the National Science and Technology Progress Award. As of October 18, 2022, the company has 232 registered intellectual property rights. In the future, the company will continue to invest in research and development, continuously develop new products and technologies to benefit more patients with structural heart disease and contribute to the cause of human health.

Company Profile

Symbol02291
Company NameSCIENTECH
ISINCNE1000057M5
Listing Date11/08/2022
Issue Price29.15
Shares Offered22.45M share
Founded01/29/2021
RegistrationChina
ChairmanJuan Chen
SecretaryXue\gaomeiying Qin
Audit InstitutionPricewaterhouseCoopers
Company CategoryMainland registration of Mainland Individuals control
Registered OfficeRoom 201, Building 41, No. 258, Xinzhuan Road, Songjiang District, Shanghai, China
Head Office and Principal Place of Business5/F, Manulife Plaza, 348 Kwun Tong Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees219
MarketHong Kong motherboard
Phone(021)37015600;(86)(21)37015633
EmailIR@scientechmed.com
Business Lepuxintai Medical Technology (Shanghai) Co., Ltd. is a Chinese investment holding company mainly engaged in R&D, manufacturing and commercialization of interventional medical devices for structural heart diseases. The company mainly operates through two divisions. The blocker business division is mainly engaged in the development and sale of a series of blockers for interventional treatment of defective congenital heart disease. The Heart Valve Business Division is mainly engaged in the research and development of heart valve medical devices. The company mainly operates in the domestic market of China.

Company Executives

  • Name
  • Position
  • Salary
  • Juan Chen
  • Executive Director,GM,Authorized Representative,Chairman,Remuneration Committee Member,Nomination Committee Chairman
  • --
  • Yuxin Zhang
  • Non-Executive Director
  • --
  • Shan Fu
  • Non-Executive Director,Remuneration Committee Member
  • --
  • Guorui Zheng
  • Nomination Committee Member,Audit Committee Members,Non-Executive Director
  • --
  • Jiali Chen
  • Independent Non-Executive Director,Nomination Committee Members,Chairman of the Audit Committee,Remuneration Committee Members
  • --
  • Yufeng Zheng
  • Remuneration Committee Chairman,Audit Committee Members,Independent Non-Executive Director,Nomination Committee Members
  • --
  • Daozhi Liu
  • Remuneration Committee Members,Nomination Committee Member,Independent Non-Executive Director
  • --
  • Xinglin Wang
  • Supervisor
  • --
  • Xiaoyong Wang
  • Supervisor
  • --
  • Weidong Qian
  • Employees representing supervisors
  • --
  • Xue Qin
  • Deputy GM,CFO,Joint Company Secretary
  • --
  • Yufeng He
  • Chief Operating Officer,Deputy GM
  • --
  • Xiani Zhang
  • Deputy GM
  • --
  • Meiying Gao
  • Authorized Representative,Joint Company Secretary
  • --
  • Zhangya Liao
  • Deputy GM
  • --
  • Kejin Qiu
  • R&D Director of Valve Division
  • --
  • Jinpeng Hu
  • R&D Director of Blockers Division
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg